Tuerkcan covers the Healthcare sector, focusing on stocks such as Crispr Therapeutics AG, Terns Pharmaceuticals, and Taysha Gene Therapies. MacroGenics has an analyst consensus of Strong Buy, with a price target consensus of $12.38. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Read More on GRTS: